Literature DB >> 2981349

Integration of spleen focus-forming virus proviruses in Friend tumor cells.

F Moreau-Gachelin, J Robert-Lezenes, F Wendling, A Tavitian, P Tambourin.   

Abstract

Using the Southern blot procedure, we studied the presumed spleen focus-forming virus (SFFV) provirus integration sites in the genome of the premalignant and the malignant cells isolated during the course of Friend erythroleukemia. Two restriction endonucleases, PstI and BamHI, discriminated the presumed integrated SFFV proviruses from the endogenous xenotropic-mink cell focus-forming viral sequences. No SFFV integration sites were detectable in the premalignant cells, suggesting a random integration of SFFV proviruses in the genome of these cells. In contrast, SFFV proviruses were detected at a single or very few sites in the genome of all malignant cells we analyzed. These results indicate that the event leading to the malignant transformation in acute Friend leukemia is clonal. In two of the six animals examined, tumors cells isolated from the spleens and the livers of individual mice showed identical SFFV integration patterns. This last result suggests that in some cases different tumors in a same leukemic animal could be derived from a unique clonal event.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981349      PMCID: PMC255034     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Friend strain of spleen focus-forming virus is a recombinant between ecotropic murine type C virus and the env gene region of xenotropic type C virus.

Authors:  D H Troxler; D Lowy; R Howk; H Young; E M Scolnick
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

3.  Production of friend leukemia virus in a mouse lung cell line.

Authors:  H Yoshikura; Y Hirokawa; M Yamada; H Sugano
Journal:  Jpn J Med Sci Biol       Date:  1967-06

4.  Malignant transformation and erythroid differentiation by polycythaemia-inducing Friend virus.

Authors:  P Tambourin; F Wendling
Journal:  Nat New Biol       Date:  1971-12-22

5.  Different pseudotypes of Friend spleen focus-forming virus induce polycythemia and erythropoietin-independent colony formation in serum-free medium.

Authors:  M E MacDonald; G R Johnson; A Bernstein
Journal:  Virology       Date:  1981-04-15       Impact factor: 3.616

6.  Quantitative colony method for tumorigenic cells transformed by two distinct strains of Friend leukemia virus.

Authors:  D L Mager; T W Mak; A Bernstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

7.  Recovery of biologically active spleen focus-forming virus from molecularly cloned spleen focus-forming virus-pBR322 circular DNA by cotransfection with infectious type C retroviral DNA.

Authors:  D L Linemeyer; S K Ruscetti; J G Menke; E M Scolnick
Journal:  J Virol       Date:  1980-09       Impact factor: 5.103

8.  Detection of tumorigenic cells in Friend virus-infected mice: an in vivo methodological investigation.

Authors:  F Moreau-Gachelin; F Wendling; P Bucau-Varlet; M Charon; P Tambourin
Journal:  J Natl Cancer Inst       Date:  1981-06       Impact factor: 13.506

9.  Helper virus is not required for in vitro erythroid transformation of hematopoietic cells by Friend virus.

Authors:  W D Hankins; S B Krantz
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

10.  Persistence and pathogenicity of defective Friend spleen focus-forming virus. Decreased transplantability of hemopoietic cells as a marker for preleukemic change.

Authors:  R J Eckner; K L Hettrick
Journal:  J Exp Med       Date:  1979-02-01       Impact factor: 14.307

View more
  9 in total

1.  Loss of pathogenicity of spleen focus-forming virus after pseudotyping with Akv.

Authors:  K S Jones; S Ruscetti; F Lilly
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  A common site for immortalizing proviral integrations in Friend erythroleukemia: molecular cloning and characterization.

Authors:  R Paul; S Schuetze; S L Kozak; D Kabat
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

3.  Analysis of integrated proviral DNA sequences with an octadecanucleotide probe designed for specific identification of spleen focus-forming virus in the mouse genome.

Authors:  F Moreau-Gachelin; L D'Auriol; J Robert-Lezenes; F Galibert; P Tambourin; A Tavitian
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

4.  A tagged helper-free Friend virus causes clonal erythroblast immortality by specific proviral integration in the cellular genome.

Authors:  C Spiro; B Gliniak; D Kabat
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

Review 5.  Hematopoietic stem cells and retroviral infection.

Authors:  Prabal Banerjee; Lindsey Crawford; Elizabeth Samuelson; Gerold Feuer
Journal:  Retrovirology       Date:  2010-02-04       Impact factor: 4.602

6.  Multistage Friend erythroleukemia: independent origin of tumor clones with normal or rearranged p53 cellular oncogenes.

Authors:  V Chow; Y Ben-David; A Bernstein; S Benchimol; M Mowat
Journal:  J Virol       Date:  1987-09       Impact factor: 5.103

7.  Retroviral endogenous transcripts related to the envelope gene of Friend spleen focus-forming virus in normal mouse tissues.

Authors:  J Robert-Lezenes; F Moreau-Gachelin; P Meneceur; P Tambourin
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

Review 8.  Multi-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperation.

Authors:  Françoise Moreau-Gachelin
Journal:  Retrovirology       Date:  2008-11-04       Impact factor: 4.602

Review 9.  c-myc protooncogene expression in mouse erythroleukemia cells.

Authors:  H M Lachman
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.